<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="//ipvsoc.org/wp-content/plugins/wordpress-seo/css/main-sitemap.xsl"?>
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.google.com/schemas/sitemap-image/1.1 http://www.google.com/schemas/sitemap-image/1.1/sitemap-image.xsd" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">
	<url>
		<loc>https://ipvsoc.org/policy_statements/vaccine-safety-statement-september-2015/</loc>
		<lastmod>2017-01-10T09:55:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://ipvsoc.org/policy_statements/hpv-vaccination-immunocompromised-hosts-april-2017/</loc>
		<lastmod>2017-04-20T08:09:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://ipvsoc.org/policy_statements/cape-town-declaration/</loc>
		<lastmod>2017-04-25T08:42:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://ipvsoc.org/policy_statements/hpv-vaccination-immunocompromised-hosts/</loc>
		<lastmod>2017-07-07T10:11:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://ipvsoc.org/policy_statements/moving-towards-elimination-cervical-cancer-public-health-problem/</loc>
		<lastmod>2018-02-22T08:52:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://ipvsoc.org/policy_statements/ipvs-statement-temporary-hpv-vaccine-shortage-implications-globally-achieve-equity/</loc>
		<lastmod>2021-05-07T10:52:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://ipvsoc.org/policy_statements/ipvs-policy-statement-addressing-the-burden-of-hpv-disease-for-indigenous-people/</loc>
		<lastmod>2022-02-22T07:51:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://ipvsoc.org/policy_statements/equity-in-cervical-cancer-prevention-for-all-and-not-just-for-some/</loc>
		<lastmod>2022-12-19T07:05:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://ipvsoc.org/policy_statements/ipvs-policy-statement-on-hpv-nucleic-acid-testing-guidance-for-those-utilising-considering-hpv-as-primary-precancer-screening-quality-assurance-and-quality-control-issues/</loc>
		<lastmod>2023-08-28T11:57:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://ipvsoc.org/policy_statements/hpv-prevention-and-control-the-way-forward/</loc>
		<lastmod>2023-08-28T12:04:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://ipvsoc.org/policy_statements/covid-19-as-a-catalyst-for-reimagining-cervical-cancer-prevention/</loc>
		<lastmod>2023-08-28T12:05:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://ipvsoc.org/policy_statements/hpv-vaccination-no-longer-supply-constraints-towards-achieving-who-vaccine-targets/</loc>
		<lastmod>2024-11-27T13:30:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://ipvsoc.org/policy_statements/an-updated-understanding-of-the-natural-history-of-cervical-human-papillomavirus-infection-clinical-implications/</loc>
		<lastmod>2025-03-19T15:22:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://ipvsoc.org/policy_statements/human-papillomavirus-based-cervical-cancer-screening-for-women-living-with-hiv/</loc>
		<lastmod>2025-11-03T12:06:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://ipvsoc.org/policy_statements/ipvs-consensus-statement/</loc>
		<lastmod>2025-12-15T09:51:09+00:00</lastmod>
	</url>
</urlset>
<!-- XML Sitemap generated by Yoast SEO -->